New Afib Drug Treatments & Rhythm Control Use — interviews Dr. James Reiffel

StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used in lower doses, and about other coming atrial-selective drugs. He also discusses the rate control vs. rhythm control decision, which varies by age and level of symptoms. Dr. Reiffel is an attending physician at New York Presbyterian Hospital, and a Professor of Clinical Medicine at the Columbia University College of Physicians & Surgeons.

Leave a Reply

Fields marked with * are required.